Literature DB >> 18087735

Utility of direct, real-time PCR in the management of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium (vanB genotype).

H A Al-Mohri1, M A Tadros, L Louie, M Vearncombe, A E Simor.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 18087735     DOI: 10.1007/s10096-007-0432-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  12 in total

1.  Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci.

Authors:  R Kariyama; R Mitsuhata; J W Chow; D B Clewell; H Kumon
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp.

Authors:  S Elsayed; N Hamilton; D Boyd; M Mulvey
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci.

Authors:  Suzanne M Paule; William E Trick; Fred C Tenover; Mary Lankford; Susan Cunningham; Valentina Stosor; Ralph L Cordell; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

4.  Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli.

Authors:  S A Ballard; E A Grabsch; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Experience with the Roche LightCycler VRE detection kit during a large outbreak of vanB2/B3 vancomycin-resistant Enterococcus faecium.

Authors:  T H Koh; R N Deepak; S Y Se-Thoe; R V T P Lin; E S C Koay
Journal:  J Antimicrob Chemother       Date:  2007-05-04       Impact factor: 5.790

6.  Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific.

Authors:  H L Young; S A Ballard; P Roffey; M L Grayson
Journal:  J Antimicrob Chemother       Date:  2007-02-06       Impact factor: 5.790

7.  Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.

Authors:  R Patel; J R Uhl; P Kohner; M K Hopkins; F R Cockerill
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

8.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs.

Authors:  L M Sloan; J R Uhl; E A Vetter; C D Schleck; W S Harmsen; J Manahan; R L Thompson; J E Rosenblatt; F R Cockerill
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay.

Authors:  Silvano Palladino; Ian D Kay; James P Flexman; Ingrid Boehm; Anna Maria G Costa; Erica J Lambert; Keryn J Christiansen
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  2 in total

1.  Comparison of real-time PCR and a microimmunofluorescence serological assay for detection of chlamydophila pneumoniae infection in an outbreak investigation.

Authors:  Alvaro J Benitez; Kathleen A Thurman; Maureen H Diaz; Laura Conklin; Newton E Kendig; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2011-10-26       Impact factor: 5.948

2.  Monitoring of bacterial pathogens at workplaces in power plant using biochemical and molecular methods.

Authors:  Anna Ławniczek-Wałczyk; Małgorzata Gołofit-Szymczak; Marcin Cyprowski; Agata Stobnicka; Rafał L Górny
Journal:  Int Arch Occup Environ Health       Date:  2017-01-25       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.